These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9243140)

  • 21. Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial.
    Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Ozduran V; Kapadia S; Nissen SE
    Eur Heart J; 2006 Jul; 27(14):1664-70. PubMed ID: 16524891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired compensatory coronary artery enlargement in atherosclerosis contributes to the development of coronary artery stenosis in diabetic patients. An in vivo intravascular ultrasound study.
    Vavuranakis M; Stefanadis C; Toutouzas K; Pitsavos C; Spanos V; Toutouzas P
    Eur Heart J; 1997 Jul; 18(7):1090-4. PubMed ID: 9243141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regression of severe atherosclerotic plaque in patients with mild elevation of LDL cholesterol.
    Schaefer S; Hussein H; Gershony GR; Rutledge JC; Kappagoda CT
    J Investig Med; 1997 Dec; 45(9):536-41. PubMed ID: 9444880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression and regression of coronary stenosis in the long-term follow-up of vasospastic angina.
    Ozaki Y; Keane D; Serruys PW
    Circulation; 1995 Nov; 92(9):2446-56. PubMed ID: 7586344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting.
    Rodés-Cabau J; Facta A; Larose E; DeLarochellière R; Déry JP; Nguyen CM; Roy L; Proulx G; Gleeton O; Barbeau G; Noël B; Rouleau J; Boudreault JR; Bertrand OF
    Am J Cardiol; 2007 Aug; 100(4):640-5. PubMed ID: 17697821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial.
    Shircore AM; Mack WJ; Selzer RH; Lee PL; Azen SP; Alaupovic P; Hodis HN
    Circulation; 1995 Nov; 92(9):2411-8. PubMed ID: 7586339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography.
    Kang J; Park KW; Lee MS; Zheng C; Han JK; Yang HM; Kang HJ; Koo BK; Kim HS
    BMC Cardiovasc Disord; 2018 Jun; 18(1):130. PubMed ID: 29954346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative analysis of atherosclerotic plaque distribution in the left main coronary artery and proximal segments of left anterior descending and left circumflex arteries in patients qualified for percutaneous coronary angioplasty].
    Gziut AI
    Ann Acad Med Stetin; 2006; 52(2):51-62; discussion 62-3. PubMed ID: 17633397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pan-coronary artery angiographic study of the association between diabetes mellitus and progression or regression of coronary atherosclerosis.
    Iijima R; Ndrepepa G; Kujath V; Harada Y; Kufner S; Schunkert H; Nakamura M; Kastrati A
    Heart Vessels; 2017 Apr; 32(4):376-384. PubMed ID: 27557547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing angiographic progression of coronary atherosclerosis with pravastatin.
    Daida H; Ouchi Y; Saito Y; Yamada N; Nishide T; Mokuno H; Kurata T; Sato H; Eto M; Ako JY; Tango T; Yamaguchi H;
    J Atheroscler Thromb; 2003; 10(1):25-31. PubMed ID: 12621161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events.
    Puri R; Wolski K; Uno K; Kataoka Y; King KL; Crowe TD; Kapadia SR; Tuzcu EM; Nissen SE; Nicholls SJ
    JACC Cardiovasc Interv; 2013 Jan; 6(1):29-35. PubMed ID: 23347860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of significant coronary artery lesions in areas of minimal disease. A common mechanism for coronary disease progression.
    Haft JI; Haik BJ; Goldstein JE; Brodyn NE
    Chest; 1988 Oct; 94(4):731-6. PubMed ID: 3168569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective natural-history study of coronary atherosclerosis.
    Stone GW; Maehara A; Lansky AJ; de Bruyne B; Cristea E; Mintz GS; Mehran R; McPherson J; Farhat N; Marso SP; Parise H; Templin B; White R; Zhang Z; Serruys PW;
    N Engl J Med; 2011 Jan; 364(3):226-35. PubMed ID: 21247313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
    Patel D; Ahmad S; Silverman A; Lindsay J
    Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.
    Brener SJ; Ivanc TB; Hu T
    J Invasive Cardiol; 2008 Jun; 20(6):261-5. PubMed ID: 18523316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International nifedipine trial on anti-atherosclerotic therapy (INTACT)--methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis.
    Jost S; Deckers J; Rafflenbeul W; Hecker H; Reiber JH; Nikutta P; Wiese B; Hugenholtz P; Lichtlen P
    Int J Card Imaging; 1990-1991; 6(2):117-33. PubMed ID: 2097305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of vessel wall morphologic appearance at sites of focal and diffuse coronary vasospasm by intravascular ultrasound.
    Koyama J; Yamagishi M; Tamai J; Kawano S; Daikoku S; Miyatake K
    Am Heart J; 1995 Sep; 130(3 Pt 1):440-5. PubMed ID: 7661058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart rate variability and progression of coronary atherosclerosis.
    Huikuri HV; Jokinen V; Syvänne M; Nieminen MS; Airaksinen KE; Ikäheimo MJ; Koistinen JM; Kauma H; Kesäniemi AY; Majahalme S; Niemelä KO; Frick MH
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1979-85. PubMed ID: 10446081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate and one-year safety of intracoronary ultrasonic imaging. Evaluation with serial quantitative angiography.
    Pinto FJ; St Goar FG; Gao SZ; Chenzbraun A; Fischell TA; Alderman EL; Schroeder JS; Popp RL
    Circulation; 1993 Oct; 88(4 Pt 1):1709-14. PubMed ID: 8403316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy.
    Løland KH; Bleie O; Blix AJ; Strand E; Ueland PM; Refsum H; Ebbing M; Nordrehaug JE; Nygård O
    Am J Cardiol; 2010 Jun; 105(11):1577-84. PubMed ID: 20494665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.